Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/1021Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tajuddin | - |
| dc.contributor.author | Nasiruddin M | - |
| dc.contributor.author | Ahmad N | - |
| dc.date.accessioned | 2008-04-16T06:13:00Z | - |
| dc.date.available | 2008-04-16T06:13:00Z | - |
| dc.date.issued | 2007-10 | - |
| dc.identifier.issn | 0972-5938 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/1021 | - |
| dc.description | 663-667 | en_US |
| dc.description.abstract | The study was conducted to evaluate cardioprotective effect of Unani formulation. Unani formulation in the dose of 100 mg / 100 gm body weight was administered per oral for 60 days before isoproterenol to test cardioprotective effect. The levels of various cardiac enzymes, glycogen and adrenal ascorbic acid were significantly altered in isoproterenol treated group as compared with control and formulation pre-treated groups. The levels were statistically similar in the groups. Unani formulation has been found to exhibit cardioprotective activity. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.relation.ispartofseries | Int. Cl.⁸: A61K36/00, A61P9/00, A61P9/04, A61P9/10, A61P9/12 | en_US |
| dc.source | IJTK Vol.6(4) [October 2007] | en_US |
| dc.subject | Bombyx mori Linn. | en_US |
| dc.subject | Nepata hindostana (Roth) Haines | en_US |
| dc.subject | Terminalia arjuna (Roxb.) Wight & Arn. | en_US |
| dc.subject | Isoproterenol | en_US |
| dc.subject | Cardioprotective activity | en_US |
| dc.subject | Unani formulation | en_US |
| dc.title | Cardioprotective effect of Unani formulation in rats | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJTK Vol.06(4) [October 2007] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJTK 6(4) (2007) 663-667.pdf | 273.22 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.